Kolexia
Bouillet Laurence Médecine interne
Bouillet Laurence
Médecine interne
Hôpital Nord Grenoble
La Tronche, France
592 Activités
1.1 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Angioedème Angio-oedèmes héréditaires Urticaire Urticaire chronique Maladie aigüe Urgences Vascularite Angioedèmes héréditaires de types I et II Maladies auto-immunes

Collaborateurs

Voir plus
Boccon-Gibod Isabelle
Boccon-Gibod Isabelle
Hôpital Nord Grenoble, La Tronche, France
Fain Olivier
Fain Olivier
Hôpital Saint-Antoine, Paris, France
Launay David
Launay David
Hôpital Huriez, Lille, France
Deroux Alban
Deroux Alban
Hôpital Nord Grenoble, La Tronche, France

Industries

Voir plus
Takeda Pharmaceutical
47 collaboration(s)
Dernière en 2023
BIOCRYST FRANCE
23 collaboration(s)
Dernière en 2023
Novartis
7 collaboration(s)
Dernière en 2023
A+A
4 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
I GET DRY: Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Essai Clinique (CHU Saint-Étienne)   01 mars 2024
C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks: C1 Inhibitor Treatment Registry to Assess the Safety and Immunological Profile of Ruconest in the Treatment of HAE Attacks
Essai Clinique (Pharming Technologies B.V.)   06 février 2024
Evaluation of Adherence to Berotralstat in Patients with Hereditary Angioedema: A Prospective Survey in Community Pharmacies
Programs and Abstracts of Papers to be Presented During Scientific Sessions: 2024 AAAAI Annual Meeting   01 février 2024
Understanding The Reasons Not To Treat All HAE Attacks And Patient Satisfaction For On-Demand Treatment (ODT). Results From The HAE Wave II Disease Specific Program™ (DSP™) 2023
Programs and Abstracts of Papers to be Presented During Scientific Sessions: 2024 AAAAI Annual Meeting   01 février 2024
Assessment of the Tolerability and Effectiveness of Berotralstat for Long-term Prophylaxis in Hereditary Angioedema: Berolife Study Interim Analysis
Programs and Abstracts of Papers to be Presented During Scientific Sessions: 2024 AAAAI Annual Meeting   01 février 2024
CRUSE -An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria.
Clinical and translational allergy   30 janvier 2024
A retrospective study (INTEGRATED) of real-world effectiveness of Lanadelumab in European patients with HAE type I/II
13th C1-inhibitor Deficiency & Angioedema Workshop - 2023   20 décembre 2023
Efficacy and safety of the oral bradykinin B2 receptor antagonist PHVS416 in treatment of Hereditary Angioedema attacks: topline results of RAPIDe-1 phase 2 trial
13th C1-inhibitor Deficiency & Angioedema Workshop - 2023   20 décembre 2023
Efficacy and safety of rituximab in angioedema with acquired C1-inhibitor deficiency
13th C1-inhibitor Deficiency & Angioedema Workshop - 2023   20 décembre 2023
Early symptom relief following treatment with the oral bradykinin 2 receptor antagonist PHVS416 in patients with hereditary angioedema attacks
13th C1-inhibitor Deficiency & Angioedema Workshop - 2023   20 décembre 2023